IDEAYA Biosciences, Inc.
IDYA
$18.58
-$0.38-2.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -151.47% | 1.80% | -33.36% | -16.54% | -23.74% |
| Total Depreciation and Amortization | -36.46% | -7.75% | 1.39% | 5.66% | -0.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.61% | 24.50% | 154,800.00% | -100.22% | -46.86% |
| Change in Net Operating Assets | 251.30% | -114.50% | 395.04% | -164.41% | 250.34% |
| Cash from Operations | -147.10% | -49.73% | 24.95% | -84.49% | 21.30% |
| Capital Expenditure | -141.14% | 53.03% | 26.57% | -58.11% | -38.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -901.11% | -128.16% | 119.72% | -217.40% | -313.87% |
| Cash from Investing | -883.77% | -129.23% | 119.37% | -216.21% | -318.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.01% | 607.20% | -88.78% | 160.83% | 380.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -99.04% | 631.19% | -88.78% | 147.78% | 406.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -245.47% | 190.19% | 253.80% | -1,035.48% | -89.38% |
